A new treatment option for certain patients with blood cancers has passed muster with the European Commission (EC).
Zemcelpro, made by ExCellThera subsidiary Cordex Biologics, is a one-time cell therapy meant to offer a curative treatment for those with hematological malignancies (also known as blood cancers) who don’t have access to necessary donor cells.





.png)

